Core Viewpoint - Alpha Teknova, Inc. will report its financial results for Q4 and the full year ended December 31, 2025, on February 26, 2026, after market close [1]. Group 1: Financial Reporting - The financial results announcement is scheduled for February 26, 2026, at the close of market [1]. - A webcast and conference call will be held on the same day at 5:30 p.m. Eastern Time for investors to access the results [2]. Group 2: Company Overview - Teknova has been innovating in the manufacture of critical reagents since 1996, supporting the life sciences industry [3]. - The company offers customizable solutions for various stages of the workflow, aiding in molecular diagnostics, synthetic biology, and emerging therapeutic modalities [3]. - Teknova operates from a 180,000 square feet facility in Hollister, California, designed for efficient production of foundational ingredients for next-generation therapies [3].

Core Viewpoint - Alpha Teknova, Inc. is set to report its financial results for the second quarter of 2025 on August 7, 2025, after market close, highlighting its ongoing role in the life sciences industry as a producer of critical reagents for novel therapies and diagnostics [1]. Group 1 - Teknova will host a webcast and conference call on August 7, 2025, at 5 p.m. Eastern Time, providing access through its Investor Relations section [2]. - The webcast will be available for replay on the company's website approximately two hours after the event [2]. Group 2 - Founded in 1996, Teknova specializes in manufacturing critical reagents for the life sciences sector, aiming to accelerate the discovery and development of new therapies [3]. - The company offers customizable solutions for various stages of the workflow, supporting sectors such as molecular diagnostics and synthetic biology [3]. - Teknova operates from a 180,000 square feet facility in Hollister, California, utilizing a modular manufacturing platform designed by experts to produce foundational ingredients for next-generation therapies [3].